← Events of the day
New mRNA melanoma jab slashes relapse and death rates
🇬🇧 United Kingdom · Technology · 1 d ago
0 / 0 / 0
mentions in 1 / 6 / 24 h
0×
pace of the last 6 h vs the previous 18
22.10 21:39 UTC
first publication
Confirmed facts
Each fact is a sentence from a source that at least two independent outlets report.
Log in A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck.
Adding it to a standard post-surgery treatment reduced by 42% the risk of melanoma returning two years after surgery, according to the most advanced study to date of this new strategy for fighting cancer.
The vaccine, called intismeran, is made with the same Nobel Prize-winning mRNA technology that was behind COVID-19 vaccines.
Moreover, the risk of distant metastasis or death fell by 38% in the vaccine group.
Full evidence via the API
Facts with links, quotes, contradictions, unknowns, changes between versions and a suggested text length. On the Business plan there is a refined layer: Claude turns the sources into atomic facts with verbatim quotes and a short summary.
How it works
Pricing
Sources
The same group number means one site, one wire agency or a near-verbatim reprint: such articles count as one independent source.
Report an error